<DOC>
	<DOCNO>NCT00332280</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety AMT2003 cancer patient advance disease . The primary evaluation criterion clinical benefit response .</brief_summary>
	<brief_title>Study Evaluate Clinical Benefit Response Cancer Patients With Advanced Disease With AMT2003 Versus Placebo</brief_title>
	<detailed_description>The study include patient variety solid tumor ( i.e . esophageal , colon , pancreatic , bronchial , gastric , hepatocellular , gall bladder , prostate gynaecological carcinoma . ) The clinical benefit response - CBR , end point provide clinical measure symptom improvement patient . The key evaluation parameter CBR assessment pain , ability perform daily activity weight change .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Female</mesh_term>
	<criteria>Cancer confirm histology cytology At least one measurable lesion Advanced disease refractory standard therapy standard therapy exist Life expectancy least 3 month Known secondary neoplasia central nervous system ( CNS ) metastases , acute chronic leukemia , lymphoma multiple myeloma Body weight 45 kg Female patient pregnant breast feed adult reproductive potential employ effective birth control method Concurrent severe uncontrolled medical disease Acute chronic liver disease Confirmed diagnosis HIV Insulin dependent diabetes mellitus/abnormal glucose tolerance test ( GTT ) /latent diabetes mellitus type I II Chemotherapy radiotherapy le 4 week prior entry Surgery less 2 week prior entry ( recovered effect surgery ) Participation clinical trial le 30 day prior entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>solid tumor</keyword>
	<keyword>clinical benefit</keyword>
	<keyword>quality life</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>colon cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>liver cancer</keyword>
	<keyword>gall bladder cancer</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>gynecological cancer</keyword>
	<keyword>lung cancer</keyword>
	<keyword>Tumors GI tract , prostate gynaecological</keyword>
</DOC>